Search
for
Sort by
Research 61–90 of 413
- Syndromes of Severe Insulin Resistance (SSIRs)
- Metabolic risk in PCOS: phenotype and adiposity impact
- Obesity and polycystic ovary syndrome
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Development of a new GC–MS/MS method for the determination of metformin in human hair
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Improving Rural Nurse Practitioner Knowledge About Polycystic Ovary Syndrome Through Continuing Education
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- A New Heterozygous Variant of c.1225_1227delTTC (p.Phe409del) in Insulin Receptor Gene Associated with Severe Insulin Resistance and Hyperandrogenemia in an Adolescent Female with Type A Severe Insulin Resistance Syndrome
- Progressive Zinc and Iron Deficiency Following Bariatric Surgery in Iraqi Patients: A 12-Month Pilot Study
- Self-esteem and body image satisfaction in women with PCOS in the Middle East: Cross-sectional social media study
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- The Efficient Pre- and Post-Operative Healthcare Strategies for Sleeve Gastrectomy Patients
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review
- Inflammasome Proteins as Biomarkers of Injury and Disease
- Evaluation of using stromal vascular fraction and platelet rich plasma in the treatment of androgenetic alopecia
- Polycystic ovary syndrome
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Rotterdam Study: 2018 update on objectives, design and main results
- The Rotterdam Study: 2016 objectives and design update
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic